Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Int J Gynecol Cancer. 2015 Sep;25(7):1292–1299. doi: 10.1097/IGC.0000000000000490

Table 3.

Patient outcomes.

No LVSI (n=200) LVSI (n=40) Total (N=240)
Characteristic N % N % N % p value
Recurrence 0.0325
   No 193 96.5 35 87.5 228 95.0
   Yes 7 3.5 5 12.5 12 5.0
Site of recurrence 0.9999
   Vaginal cuff 4 57.1 3 60.0 7 58.3
   Pelvis 3 42.9 2 40.0 5 41.7
Treatment at recurrence 0.5303
   Pelvic RT 1 14.3 0 0.0 1 8.3
   Chemotherapy 1 14.3 0 0.0 1 8.3
   Chemoradiotherapy 1 14.3 2 40.0 3 25.0
   Resection + chemotherapy 0 0.0 2 40.0 2 16.7
   Pelvic RT + brachytherapy 1 14.3 1 20.0 2 16.7
   Pelvic RT + chemotherapy 2 28.6 0 0.0 2 16.7
   Other 1 14.3 0 0.0 1 8.3
Outcome at last follow-up 0.0341
   No evidence of disease 192 96.0 35 87.5 227 94.5
   Alive with disease 3 1.5 0 0.0 3 1.3
   Died of disease 1 0.5 1 2.5 2 0.8
   Died of other cause 4 2.0 4 10.0 8 3.3

RT, external beam radiation therapy.